Evidence map›Paper›PMID 29238213›Full record

ArticleJournal of pain research2017

First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid.

Chhaya V Sharma, Jamie H Long, Seema Shah, Junia Rahman, David Perrett, Samir S Ayoub, Vivek Mehta

Open access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Mechanistic Insights into the Analgesic Action of Acetaminophen: Its Bioactive Metabolite Induces Peripheral Analgesia in Addition to Central Analgesia.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Review
  2. The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Paracetamol (Acetaminophen) and the Developing Brain.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. A Guide to Targeting the Endocannabinoid System in Drug Design.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Chhaya V SharmaPain & Anaesthesia Research Centre, St Bartholomew's and The Royal London Hospitals, Barts Health NHS Trust, London, UK.
Jamie H LongBarts & The London School of Medicine, Queen Mary University of London, London, UK.
Seema ShahPain & Anaesthesia Research Centre, St Bartholomew's and The Royal London Hospitals, Barts Health NHS Trust, London, UK.
Junia RahmanPain & Anaesthesia Research Centre, St Bartholomew's and The Royal London Hospitals, Barts Health NHS Trust, London, UK.
David PerrettBioAnalytical Science, Barts & The London School of Medicine, Queen Mary University of London, London, UK.
Samir S AyoubSchool of Health, Sport and Bioscience, Medicines Research Group, University of East London, London, UK.
Vivek MehtaPain & Anaesthesia Research Centre, St Bartholomew's and The Royal London Hospitals, Barts Health NHS Trust, London, UK.
Barts Health NHS Trust · GBQueen Mary University of London · GBRoyal London Hospital · GBUniversity of East London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paracetamol is arguably the most commonly used analgesic and antipyretic drug worldwide, however its mechanism of action is still not fully established. It has been shown to exert effects through multiple pathways, some actions suggested to be mediated via N-arachidonoylphenolamine (AM404). AM404, formed through conjugation of paracetamol-derived p-aminophenol with arachidonic acid in the brain, is an activator of the capsaicin receptor, TRPV1, and inhibits the reuptake of the endocannabinoid, anandamide, into postsynaptic neurons, as well as inhibiting synthesis of PGE

Indexed as

acetaminophenAM404N-arachidonoylphenolamineparacetamolparacetamol: mechanism of actionpharmacology - theories of analgesic action

Identifiers

PMID29238213
PMCPMC5716395
OpenAlexW2769311760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.